Literature DB >> 35853442

Adaptation and dosimetric commissioning of a synchrotron-based proton beamline for FLASH experiments.

Ming Yang1, Xiaochun Wang1, Fada Guan2, Uwe Titt1, Kiminori Iga3, Dadi Jiang4, Takeshi Takaoka3, Satoshi Tootake5, Tadashi Katayose5, Masumi Umezawa5, Emil Schüler1, Steven Frank4, Steven H Lin4, Narayan Sahoo1, Albert C Koong4, Radhe Mohan1, X Ronald Zhu1.   

Abstract

Objective. Irradiation with ultra-high dose rates (>40 Gy s-1), also known as FLASH irradiation, has the potential to shift the paradigm of radiation therapy because of its reduced toxicity to normal tissues compared to that of conventional irradiations. The goal of this study was to (1) achieve FLASH irradiation conditions suitable for pre-clinicalin vitroandin vivobiology experiments using our synchrotron-based proton beamline and (2) commission the FLASH irradiation conditions achieved.Approach. To achieve these suitable FLASH conditions, we made a series of adaptations to our proton beamline, including modifying the spill length and size of accelerating cycles, repurposing the reference monitor for dose control, and expanding the field size with a custom double-scattering system. We performed the dosimetric commissioning with measurements using an Advanced Markus chamber and EBT-XD films as well as with Monte Carlo simulations.Main results. Through adaptations, we have successfully achieved FLASH irradiation conditions, with an average dose rate of up to 375 Gy s-1. The Advanced Markus chamber was shown to be appropriate for absolute dose calibration under our FLASH conditions with a recombination factor ranging from 1.002 to 1.006 because of the continuous nature of our synchrotron-based proton delivery within a spill. Additionally, the absolute dose measured using the Advanced Markus chamber and EBT-XD films agreed well, with average and maximum differences of 0.32% and 1.63%, respectively. We also performed a comprehensive temporal analysis for FLASH spills produced by our system, which helped us identify a unique relationship between the average dose rate and the dose in our FLASH irradiation.Significance.We have established a synchrotron-based proton FLASH irradiation platform with accurate and precise dosimetry that is suitable for pre-clinical biology experiments. The unique time structure of the FLASH irradiation produced by our synchrotron-based system may shed new light onto the mechanism behind the FLASH effect.
© 2022 Institute of Physics and Engineering in Medicine.

Entities:  

Keywords:  FLASH; dosimetric commissioning; proton; synchrotron

Mesh:

Substances:

Year:  2022        PMID: 35853442      PMCID: PMC9422888          DOI: 10.1088/1361-6560/ac8269

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   4.174


  24 in total

1.  The M. D. Anderson proton therapy system.

Authors:  Alfred Smith; Michael Gillin; Martin Bues; X Ronald Zhu; Kazumichi Suzuki; Radhe Mohan; Shiao Woo; Andrew Lee; Ritsko Komaki; James Cox; Kazuo Hiramoto; Hiroshi Akiyama; Takayuki Ishida; Toshie Sasaki; Koji Matsuda
Journal:  Med Phys       Date:  2009-09       Impact factor: 4.071

2.  High dose-per-pulse electron beam dosimetry: Usability and dose-rate independence of EBT3 Gafchromic films.

Authors:  Maud Jaccard; Kristoffer Petersson; Thierry Buchillier; Jean-François Germond; Maria Teresa Durán; Marie-Catherine Vozenin; Jean Bourhis; François O Bochud; Claude Bailat
Journal:  Med Phys       Date:  2017-02-08       Impact factor: 4.071

3.  High dose-per-pulse electron beam dosimetry - A model to correct for the ion recombination in the Advanced Markus ionization chamber.

Authors:  Kristoffer Petersson; Maud Jaccard; Jean-François Germond; Thierry Buchillier; François Bochud; Jean Bourhis; Marie-Catherine Vozenin; Claude Bailat
Journal:  Med Phys       Date:  2017-02-28       Impact factor: 4.071

4.  Experimental Platform for Ultra-high Dose Rate FLASH Irradiation of Small Animals Using a Clinical Linear Accelerator.

Authors:  Emil Schüler; Stefania Trovati; Gregory King; Frederick Lartey; Marjan Rafat; Manuel Villegas; A Joe Praxel; Billy W Loo; Peter G Maxim
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-09-20       Impact factor: 7.038

5.  Experimental Set-up for FLASH Proton Irradiation of Small Animals Using a Clinical System.

Authors:  Annalisa Patriarca; Charles Fouillade; Michel Auger; Frédéric Martin; Frédéric Pouzoulet; Catherine Nauraye; Sophie Heinrich; Vincent Favaudon; Samuel Meyroneinc; Rémi Dendale; Alejandro Mazal; Philip Poortmans; Pierre Verrelle; Ludovic De Marzi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-07-11       Impact factor: 7.038

6.  Ion recombination and polarity correction factors for a plane-parallel ionization chamber in a proton scanning beam.

Authors:  Małgorzata Liszka; Liliana Stolarczyk; Magdalena Kłodowska; Anna Kozera; Dawid Krzempek; Natalia Mojżeszek; Anna Pędracka; Michael Patrick Russell Waligórski; Paweł Olko
Journal:  Med Phys       Date:  2017-12-16       Impact factor: 4.071

7.  Use of a Victoreen 500 electrometer to determine ionization chamber collection efficiencies.

Authors:  P R Almond
Journal:  Med Phys       Date:  1981 Nov-Dec       Impact factor: 4.071

Review 8.  Biological Benefits of Ultra-high Dose Rate FLASH Radiotherapy: Sleeping Beauty Awoken.

Authors:  M-C Vozenin; J H Hendry; C L Limoli
Journal:  Clin Oncol (R Coll Radiol)       Date:  2019-04-19       Impact factor: 4.126

Review 9.  Ultra-high dose rate electron beams and the FLASH effect: From preclinical evidence to a new radiotherapy paradigm.

Authors:  Emil Schüler; Munjal Acharya; Pierre Montay-Gruel; Billy W Loo; Marie-Catherine Vozenin; Peter G Maxim
Journal:  Med Phys       Date:  2022-01-19       Impact factor: 4.506

Review 10.  FLASH and minibeams in radiation therapy: the effect of microstructures on time and space and their potential application to protontherapy.

Authors:  Alejandro Mazal; Yolanda Prezado; Carme Ares; Ludovic de Marzi; Annalisa Patriarca; Raymond Miralbell; Vincent Favaudon
Journal:  Br J Radiol       Date:  2020-02-12       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.